Zymeworks (ZYME) Stock Statistics & Valuation Metrics

Zymeworks has a market cap or net worth of $1.71B. The enterprise value is $1.64B.

Zymeworks has 74,836,530 shares outstanding. The number of shares has decreased by -2.65% in one year.

Zymeworks’s return on equity (ROE) is -0.36 and return on invested capital (ROIC) is -36.32%.

The current PE Ratio of Zymeworks is ―. Zymeworks’s PEG ratio is 1.56.

In the last 12 months, Zymeworks had revenue of 76.30M and earned -122.69M in profits. Earnings per share was -1.62.

In the last 12 months, operating cash flow was -64.25M and capital expenditures -1.95M, giving a free cash flow of -66.20M billion.

Zymeworks pays an annual dividend of ―, resulting in a dividend yield of ―

Zymeworks upcoming earnings date is Mar 11, 2026, Before Open (Confirmed).

Zymeworks as a current ratio of 3.40, with Debt / Equity ratio of 5.91%

In the past 12 months, Zymeworks has paid 6.08M in taxes.

Zymeworks EV to EBITDA ratio is -9.78, with an EV/FCF ratio of -9.40.

Zymeworks has $251.93M in cash and marketable securities with $18.90M in debt, giving a net cash position of $233.03M billion.

Gross margin is 100.00%, with operating margin of -179.69%, and net profit margin of -160.80%.

The average price target for Zymeworks is $35.55, which is 11.43% higher than the current price. The consensus rating is Strong Buy